BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10500792)

  • 1. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
    Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
    Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
    Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia.
    Hart SM; Ganeshaguru K; Hoffbrand AV; Prentice HG; Mehta AB
    Leukemia; 1994 Dec; 8(12):2163-8. PubMed ID: 7808005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia.
    Schneider E; Cowan KH; Bader H; Toomey S; Schwartz GN; Karp JE; Burke PJ; Kaufmann SH
    Blood; 1995 Jan; 85(1):186-93. PubMed ID: 7528566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
    Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
    Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
    Pallis M; Turzanski J; Langabeer S; Russell NH
    Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia.
    Ogretmen B; Barredo JC; Safa AR
    J Pediatr Hematol Oncol; 2000; 22(1):45-9. PubMed ID: 10695821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
    Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
    Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical significance of multidrug resistance associated protein(MRP) gene expression in acute leukemia].
    Wang F; Dong Z; Luo J
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):63-6. PubMed ID: 10921103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy.
    Fedasenka UU; Shman TV; Savitski VP; Belevcev MV
    Exp Oncol; 2008 Sep; 30(3):248-52. PubMed ID: 18806751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.
    Beck J; Handgretinger R; Dopfer R; Klingebiel T; Niethammer D; Gekeler V
    Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
    Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
    Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells.
    Ichihashi N; Kitajima Y
    Br J Dermatol; 2001 Apr; 144(4):745-50. PubMed ID: 11298532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia.
    Huh HJ; Park CJ; Jang S; Seo EJ; Chi HS; Lee JH; Lee KH; Seo JJ; Moon HN; Ghim T
    J Korean Med Sci; 2006 Apr; 21(2):253-8. PubMed ID: 16614510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance-associated protein 1 predicts relapse in Iranian childhood acute lymphoblastic leukemia.
    Mahjoubi F; Akbari S
    Asian Pac J Cancer Prev; 2012; 13(5):2285-9. PubMed ID: 22901208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 gene and its family genes Bax, Bcl-Xl as well as Fas/Apo-1 and their clinical significance in acute leukemia.
    Chen Y; Zhou J; Yue B; Xiang Z; Song X; Li C; Wang B
    Chin Med J (Engl); 1998 Aug; 111(8):682-5. PubMed ID: 11245018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
    Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
    Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.